Zenith Health Care Ltd
NSE: BSE: 530665
₹3.17
(-5.65%)
Sun, 29 Mar 2026, 09:13 am
Market Cap170.35M
PE Ratio37.29
Dividend0
Health Technology
Pharmaceuticals: Other
24.5KZenith Health Care Analysis
dividend
- Unable to evaluate Zenith Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Zenith Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Zenith Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Zenith Healthcare is profitable, therefore cash runway is not a concern.
- Zenith Healthcare is profitable, therefore cash runway is not a concern.
- Zenith Healthcare has no debt, it does not need to be covered by operating cash flow.
- Zenith Healthcare has no debt, it does not need to be covered by short term assets.
- Zenith Healthcare has no long term commitments.
- Zenith Healthcare currently has no debt however we can't compare to 5 years ago as we have no data for that period.
- Zenith Healthcare has no debt, therefore coverage of interest payments is not a concern.
- Zenith Healthcare has no debt.
- High level of physical assets or inventory.
management
- The tenure for the Zenith Healthcare board of directors is about average.
- Mahendra's remuneration is lower than average for companies of similar size in India.
- Mahendra's compensation has been consistent with company performance over the past year, both up more than 20%.
- The tenure for the Zenith Healthcare management team is about average.
misc
- Zenith Healthcare is not covered by any analysts.
- Zenith Healthcare has significant price volatility in the past 3 months.
past
- Zenith Healthcare has delivered over 20% year on year earnings growth in the past 5 years.
- Zenith Healthcare has become profitable over the past 3 years. This is considered to be a significant improvement in its use of capital (Return on Capital Employed).
- Zenith Healthcare's 1-year earnings growth is less than its 5-year average (20.7% vs 58.1%)
- Zenith Healthcare used its assets less efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
- Zenith Healthcare has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Zenith Healthcare's earnings growth has not exceeded the IN Pharmaceuticals industry average in the past year (20.7% vs 22.7%).
value
- Zenith Healthcare's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Zenith Healthcare is good value based on assets compared to the IN Pharmaceuticals industry average.
- BSE:530665 is up 12% outperforming the Pharmaceuticals industry which returned 6.8% over the past month.
- BSE:530665 is up 12% outperforming the market in India which returned 8% over the past month.
- Zenith Healthcare's share price is below the future cash flow value, but not at a substantial discount (< 40%).
- Zenith Healthcare is overvalued based on earnings compared to the IN Pharmaceuticals industry average.
- Zenith Healthcare is overvalued based on earnings compared to the India market.
- 530665 underperformed the Pharmaceuticals industry which returned 26.7% over the past year.
- 530665 underperformed the Market in India which returned -14.5% over the past year.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800